Synta Pharmaceuticals Corp.
 (SNTA)

- NASDAQ
What's your position on ?
Bullish
Bearish
Why are you ish?
Skip
Post
You voted ish on Vote again
Posts appear on the My Feed page of subscribers to this ticker
Last vote:
  • tonyczyk49 | Send Message 23 Dec 2015

    $SNTA will this stock survive ?
    Reply (1)
    • Chancer | Send Message 24 Dec 2015
      : Probably not.
      • timtrading | Send Message 3 Dec 2015

        oversold stock screener $HPQ,$UGAZ,$X,$UNG,$WPZ,$ARP,$NMBL,$GDP,$SNTA,$MEMP http://bit.ly/1LmTjMh
        Reply (3)
      • View all 3 replies
        • X Oil-Field | Send Message 12 Jan
          : OPEC has no plan for emergency meeting on oil drop: Delegates. http://bit.ly/1mTOjLt http://bit.ly/1KGFNnJ TheEconomicTimes $USO $OIL
        • X Oil-Field | Send Message 12 Jan
          : Goodrich Petroleum Corporation $GDP Receives Continued Listing Standard Notice From NYSE. http://prn.to/1kgasSW PR/Newswire
          • timtrading | Send Message 19 Nov 2015

            oversold stocks screener $HPQ,$SKX,$GPRO,$DKS,$SLV,$SNTA,$CMLS,$SALT,$INFY,$ICON http://bit.ly/1LmTjMh
            Reply
              • BestPick | Send Message 12 Nov 2015

                $SNTA massive buying inside was somewhat confidence, but I guess sometimes it's meaningless on this one. Look for any analysis.
                Reply (1)
                • BestPick | Send Message 12 Nov 2015
                  : KOVNER BRUCE, is this guy a billionaire ?
                  • timtrading | Send Message 8 Nov 2015
                    Reply
                      • Gary Inesting | Send Message 21 Oct 2015

                        $VRX $SNTA Analysts Weigh In on Two Collapsing Healthcare Stocks http://bit.ly/1MF7pK9
                        Reply
                          • bobby kim | Send Message 21 Oct 2015

                            Is this coming back? $SNTA
                            Reply (4)
                          • View all 4 replies
                            • Insider-Alerts | Send Message 27 Oct 2015
                              : monument - price target absolutely worthless. how good was Roth with it at $27? at $13? now Roth is at $1.00...don't be naïve.
                            • Insider-Alerts | Send Message 27 Oct 2015
                              : Prognostication: wait for end of year tax selling to really kick in first couple weeks of Dec. Pick up shares for quick flip on Jan bounce
                              • monumentalgains | Send Message 21 Oct 2015

                                $SNTA = ouch!!!
                                Reply (1)
                                • Jefferson Pham | Send Message 21 Oct 2015
                                  : yes
                                  • Gary Inesting | Send Message 16 Oct 2015

                                    $SRPT $SNTA Roth Capital Biotech Insights http://bit.ly/1LSIceM
                                    Reply (2)
                                    • Insider-Alerts | Send Message 16 Oct 2015
                                      : Joseph Pantginis - ranked #3,741 out of 3,806 analysts (#8,178 out of 8,463 overall experts). Not very good at what he does.
                                    • Insider-Alerts | Send Message 21 Oct 2015
                                      : So much for that idea...Mr. Pantginis proves his ineptitude once again...Roth downgrades to $1.00 price target.
                                      • Gary Inesting | Send Message 16 Oct 2015

                                        $SNTA Roth Capital Reiterates Buy on Synta Pharmaceuticals Corp. Following Management Meetings http://bit.ly/1LSv2OQ
                                        Reply (5)
                                      • View all 5 replies
                                        • Insider-Alerts | Send Message 21 Oct 2015
                                          : Roth downgrades to $1.00 price target only 5 days later. Obviously they came away from the Management Meetings with the incorrect ideas.
                                        • Insider-Alerts | Send Message 21 Oct 2015
                                          : But hey - management loves them and because of reiterating the Buy and $13 price target, Synta will use Roth as lead for next capital raise.
                                          Company Description
                                          Synta Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in research, development and commercialization of novel oncology medicines that have the potential to change the lives of cancer patients.